Ebola – The industry's response in vaccines
This article was originally published in Scrip
Executive Summary
The latest Ebola epidemic, which the WHO says has now claimed more than 9,600 lives, has focused attention on the long-term need for a prophylactic vaccine to prevent future outbreaks of this size.